Myasthenia gravis trials in Israel

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Enrolling by invitation
  Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis

  Where

  Jerusalem

  Age

  2 years to 18 years

  People

  12 worldwide

  Run by

  argenx

  See details and how to joinNCT05374590 · EU 2023-507379-23-00
• Phase 3Taking people
  Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

  Where

  Haifa, Tel Aviv

  Age

  18 years to 74 years

  People

  115 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT07217587 · EU 2025-521130-28-00
• Phase 2/3Taking people
  A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis

  Where

  Jerusalem, Petah Tikvah, Tel Aviv

  Age

  2 years to 17 years

  People

  12 worldwide

  Run by

  argenx

  See details and how to joinNCT06392386 · EU 2023-506159-12-00
• Phase 1Taking people
  Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

  Where

  Jerusalem

  Age

  18 years to 80 years

  People

  120

  Run by

  Polina Stepensky

  See details and how to joinNCT07085676
• Phase 4Not yet taking people in Israel
  Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis

  Where

  Haifa

  Age

  18 years to 99 years

  People

  16

  Run by

  Rambam Health Care Campus

  See details and how to joinNCT06688253